Pfizer Vaccine Shortfalls: Warp Speed’s Perna Takes Responsibility, Cites Lot Release Confusion
Executive Summary
States had received less than they expected, and Operation Warp Speed and Pfizer had taken swipes at each other, but that all seems smoothed over now – even though it’s still not exactly clear how much of Pfizer’s COVID vaccine will be available to the US by the end of year.
You may also be interested in...
Biden Wants To Release More COVID-19 Vaccine, But Also Maintain Strategic Reserve
Rather than holding half of all vaccines produced to ensure administration of the second dose, only a portion would be held to cover for manufacturing or other problems.
Expanded Distribution For COVID Vaccines Will Boost Options – And Logistical Complications
Operation Warp Speed officials eye the Moderna vaccine and upcoming one-shot Janssen product to widen the immunization campaign’s reach, but more products also could bring more problems.
Operation Warp Speed Angles For Greater Role In Pfizer COVID-19 Vaccine Manufacturing
Government offers help securing supplies in return for another 100 million doses by Q2. That would mean abandoning Pfizer’s preferred arms-length relationship.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: